Actively Recruiting
A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis
Led by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Updated on 2026-03-24
36
Participants Needed
32
Research Sites
67 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study, all subjects need to use TQH2929 injection/placebo. The aim was to demonstrate the efficacy and safety of TQH2929 injection in patients with acute exacerbations of generalized pustular psoriasis, with a total of 36 subjects.
CONDITIONS
Official Title
A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 75 years at screening, any gender
- Diagnosed with generalized pustular psoriasis according to 2017 ERASPEN criteria
- Experiencing an acute flare-up of generalized pustular psoriasis
- Able to read, understand, and willing to sign informed consent
- Willing and able to comply with study visits and procedures
- Female participants of childbearing potential agree to use contraception during the study and for 6 months after
You will not qualify if you...
- Pustules limited only to psoriasis plaques (psoriasis vulgaris)
- Skin or medical conditions that interfere with treatment response evaluation
- Severe, progressive, or uncontrolled disease deemed unsuitable by investigator
- Abnormal serum virology during screening
- Active tuberculosis, recent contact with tuberculosis, or positive IGRA test
- Serious infection requiring hospitalization within 2 months before baseline
- Active infection needing systemic antibiotic, antifungal, or antiviral treatment within 2 weeks before baseline
- Opportunistic infection within 6 months prior to baseline
- Live (attenuated) vaccine within 12 weeks prior to baseline
- Major surgery within 4 weeks prior to baseline or planned during study
- Blood transfusion within 4 weeks prior to baseline
- Participation in other drug or device trials within 4 weeks before baseline
- Known or suspected immunodeficiency compromising immune status
- Active malignancy or history of malignancy
- Alcohol, drug, or known drug dependence
- Pregnant or breastfeeding women
- Unable to tolerate intravenous infusion administration
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 32 locations
1
Peking University First Hospita
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
2
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Not Yet Recruiting
3
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350000
Not Yet Recruiting
4
Southern Medical University Dermatology Hospital
Guangzhou, Guangdong, China, 510091
Not Yet Recruiting
5
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510120
Not Yet Recruiting
6
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China, 550004
Not Yet Recruiting
7
The Second Hospital Of Hebei Medical University
Shijiazhuang, Hebei, China, 050000
Not Yet Recruiting
8
The Second Affiliated Hospital of Henan University of science and technology
Luoyang, Henan, China, 471000
Not Yet Recruiting
9
Zhengzhou Central Hospital
Zhengzhou, Henan, China, 450000
Not Yet Recruiting
10
Henan Provincial People's Hospital
Zhengzhou, Henan, China, 450003
Not Yet Recruiting
11
The fifth Affiliated hospital of zhengzhou university
Zhengzhou, Henan, China, 450052
Not Yet Recruiting
12
Shiyan Renmin Hospital
Shiyan, Hubei, China, 442000
Not Yet Recruiting
13
Renmin Hospital of Wuhan University
Wuhan, Hubei, China, 430060
Not Yet Recruiting
14
The First Hospital of Hunan University of Chinese Medicine
Changsha, Hunan, China, 410007
Not Yet Recruiting
15
Xiangya Hospital of Central South University
Changsha, Hunan, China, 410008
Not Yet Recruiting
16
The General Hospital Of Hunan University Of Medicine
Huaihua, Hunan, China, 41800
Not Yet Recruiting
17
The first hospital of jilin university
Changchun, Jilin, China, 130012
Not Yet Recruiting
18
The first hospital of china medical university
Shenyang, Liaoning, China, 110001
Not Yet Recruiting
19
Shandong First Medical University Affiliated Dermatology Hospital
Jinan, Shandong, China, 250022
Not Yet Recruiting
20
Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, China, 200443
Not Yet Recruiting
21
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China, 710061
Not Yet Recruiting
22
Chengdu Second People's Hospital
Chengdu, Sichuan, China, 610000
Not Yet Recruiting
23
Sichuan Provincial People' s Hospital
Chengdu, Sichuan, China, 610000
Not Yet Recruiting
24
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, China, 646000
Not Yet Recruiting
25
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, China, 646000
Not Yet Recruiting
26
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China, 300052
Not Yet Recruiting
27
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China, 300120
Not Yet Recruiting
28
People's Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang, China, 830001
Not Yet Recruiting
29
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China, 830013
Not Yet Recruiting
30
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China, 650032
Not Yet Recruiting
31
Jiaxing First Hospital
Jiaxing, Zhejiang, China, 314001
Not Yet Recruiting
32
The first affiliated hospital of ningbo university
Ningbo, Zhejiang, China, 315020
Not Yet Recruiting
Research Team
H
Hang Li, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here